Lo-Ciganic WH - Search Results

1

Using human factors methods to mitigate bias in artificial intelligence-based clinical decision support.

Militello LG, Diiulio J, Wilson DL, Nguyen KA, Harle CA, Gellad W, Lo-Ciganic WH. Militello LG, et al. Among authors: lo ciganic wh. J Am Med Inform Assoc. 2024 Nov 21:ocae291. doi: 10.1093/jamia/ocae291. Online ahead of print. J Am Med Inform Assoc. 2024. PMID: 39569464

2

The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders.

Park H, Jiang X, Song HJ, Lo Re V 3rd, Childs-Kean LM, Lo-Ciganic WH, Cook RL, Nelson DR. Park H, et al. Hepatology. 2021 Aug;74(2):566-581. doi: 10.1002/hep.31732. Epub 2021 Jul 1. Hepatology. 2021. PMID: 33544904 Free PMC article.

3

Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Cochran G, et al. Subst Abus. 2015;36(2):192-202. doi: 10.1080/08897077.2014.993491. Epub 2015 Feb 11. Subst Abus. 2015. PMID: 25671499 Free PMC article. Review.

4

Using machine learning to examine medication adherence thresholds and risk of hospitalization.

Lo-Ciganic WH, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF. Lo-Ciganic WH, et al. Med Care. 2015 Aug;53(8):720-8. doi: 10.1097/MLR.0000000000000394. Med Care. 2015. PMID: 26147866 Free PMC article.

5

Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.

Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Gordon AJ, et al. J Addict Med. 2015 Nov-Dec;9(6):470-7. doi: 10.1097/ADM.0000000000000164. J Addict Med. 2015. PMID: 26517324

6

Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.

Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM. Lo-Ciganic WH, et al. Addiction. 2016 May;111(5):892-902. doi: 10.1111/add.13270. Epub 2016 Jan 30. Addiction. 2016. PMID: 26662858

7

Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Lo-Ciganic WH, Gellad WF, Huskamp HA, Choudhry NK, Chang CC, Zhang R, Jones BL, Guclu H, Richards-Shubik S, Donohue JM. Lo-Ciganic WH, et al. Med Care. 2016 Jul;54(7):725-32. doi: 10.1097/MLR.0000000000000549. Med Care. 2016. PMID: 27116109 Free PMC article.

8

Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow.

Gordon A, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Donohue JM. Gordon A, et al. J Addict Med. 2016 May-Jun;10(3):210-1. doi: 10.1097/ADM.0000000000000210. J Addict Med. 2016. PMID: 27223837 No abstract available.

9

Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.

Lo-Ciganic WH, Donohue JM, Jones BL, Perera S, Thorpe JM, Thorpe CT, Marcum ZA, Gellad WF. Lo-Ciganic WH, et al. J Gen Intern Med. 2016 Sep;31(9):1052-60. doi: 10.1007/s11606-016-3747-6. Epub 2016 May 26. J Gen Intern Med. 2016. PMID: 27229000 Free PMC article.

10

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM. Cochran G, et al. Med Care. 2017 Mar;55(3):291-298. doi: 10.1097/MLR.0000000000000676. Med Care. 2017. PMID: 27984346 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters